End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
99.08 CHF | -0.56% | +4.38% | +1.39% |
01-10 | BNP Paribas Exane Upgrades DSM-Firmenich to Outperform, Raises PT | MT |
01-09 | Stifel Upgrades DSM-Firmenich to Buy, Lifts PT | MT |
Capitalization | 26.14B 27.18B 24.67B 22.1B 38.92B 2,343B 43.4B 300B 111B 967B 102B 99.84B 4,231B | P/E ratio 2024 * |
58.6x | P/E ratio 2025 * | 33x |
---|---|---|---|---|---|
Enterprise value | 29.03B 30.19B 27.41B 24.54B 43.23B 2,603B 48.21B 333B 123B 1,074B 113B 111B 4,699B | EV / Sales 2024 * |
2.27x | EV / Sales 2025 * | 2.14x |
Free-Float |
25.03% | Yield 2024 * |
2.52% | Yield 2025 * | 2.59% |
Last Transcript: DSM-Firmenich
1 day | -0.56% | ||
1 week | +4.38% | ||
Current month | +1.39% | ||
1 month | +1.23% | ||
3 months | -16.10% | ||
6 months | -10.58% | ||
Current year | +1.39% |
Director | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 2019-12-31 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 2023-08-31 |
Ipek Ozsuer
CTO | Chief Tech/Sci/R&D Officer | 45 | 2023-04-30 |
Manager | Title | Age | Since |
---|---|---|---|
Thomas Leysen
CHM | Chairman | 64 | 2023-01-31 |
Director/Board Member | 63 | 2023-01-31 | |
André Pometta
BRD | Director/Board Member | 60 | 2023-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.82% | 0 M€ | +15.09% | - | |
0.51% | 0 M€ | +6.14% | - | |
0.22% | 0 M€ | -.--% | - | |
0.20% | 0 M€ | -.--% |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.56% | +4.38% | +9.03% | - | 27.18B | ||
+1.42% | +5.48% | +26.23% | +50.36% | 1,010B | ||
-0.12% | +0.27% | +0.30% | +160.00% | 241B | ||
-0.05% | +1.59% | +10.86% | +6.54% | 145B | ||
+1.33% | +4.78% | +30.87% | -18.75% | 76.8B | ||
+0.18% | +2.68% | +0.34% | +7.87% | 75.71B | ||
-1.41% | -1.93% | +116.95% | +575.02% | 45.12B | ||
-0.46% | +0.47% | +16.44% | +74.04% | 34.44B | ||
-0.16% | -4.65% | -32.19% | -50.80% | 33.54B | ||
+2.21% | +3.38% | +12.00% | -19.23% | 22.34B | ||
Average | +0.24% | +2.47% | +19.08% | +87.23% | 171.04B | |
Weighted average by Cap. | +0.86% | +4.33% | +20.93% | +68.83% |
2024 * | 2025 * | |
---|---|---|
Net sales | 12.81B 13.33B 12.1B 10.83B 19.08B 1,149B 21.28B 147B 54.47B 474B 49.98B 48.95B 2,074B | 13.42B 13.96B 12.67B 11.35B 19.99B 1,203B 22.29B 154B 57.05B 496B 52.35B 51.27B 2,173B |
Net income | 453M 471M 428M 383M 675M 40.63B 753M 5.2B 1.93B 16.76B 1.77B 1.73B 73.37B | 818M 850M 772M 691M 1.22B 73.3B 1.36B 9.38B 3.48B 30.24B 3.19B 3.12B 132B |
Net Debt | 2.89B 3.01B 2.73B 2.45B 4.31B 259B 4.8B 33.18B 12.3B 107B 11.28B 11.05B 468B | 2.54B 2.65B 2.4B 2.15B 3.79B 228B 4.23B 29.18B 10.82B 94.11B 9.92B 9.72B 412B |
Date | Price | Change | Volume |
---|---|---|---|
25-01-20 | 99.08 CHF | -0.56% | 319,588 |
25-01-17 | 99.64 CHF | +1.22% | 452,878 |
25-01-16 | 98.44 CHF | +1.30% | 423,641 |
25-01-15 | 97.18 CHF | +2.71% | 488,821 |
25-01-14 | 94.62 CHF | -0.32% | 369,505 |
End-of-day quote Euronext Amsterdam, January 19, 2025
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- DSFIR Stock
MarketScreener is also available in this country: United States.
Switch edition